X0708 D LIVE 0001829093 Nuvation Bio Inc. 1500 BROADWAY SUITE 1401 NEW YORK NY NEW YORK 10036 650-245-3818 DELAWARE RePharmation Inc. None Corporation true 2018 David Hung, M.D. 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Executive Officer Director Kim Blickenstaff 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Director Michelle Doig 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Director Robert Bazemore 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Director Claudio Nessi 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Director W. Anthony Vernon 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Director Daniel Welch 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Director Kathryn E. Falberg 1500 Broadway Suite 1401 New York NY NEW YORK 10036 Director Pharmaceuticals Decline to Disclose 06b false 2019-06-17 true true false 0 275348195 275348195 0 Includes $15,000,000 in value of cancelled convertible instruments. false 57 0 0 0 false Nuvation Bio Inc. /s/ David Hung, M.D. David Hung, M.D. Chief Executive Officer 2020-10-20